Patients with rare tumor types or younger ages should look for fusion events in addition to common mutations with approved drugs.

“i guess i would say approved drugs the sort of very common mutations all good doctors are going to test for the pair somebody with the trial is you did your friend that's really terrific i think particularly people who suffer from rarer tumor types at younger ages they should also keep an eye out for fusion events those are really important to know about”